The rapid development of the different disciplines in the fields of biological and biomedical research (such as genomics, proteomics, and transcriptomics) in recent decades has led to exponential ...
To account for biological complexity, candidate therapeutics are tested across a range of assays in diverse cellular contexts before advancing to model systems such as organoids, xenografts, animals ...
Deciding the size of a minimum dominating set is a classic NP-complete problem. It has found increasing utility as the basis for classifying vertices in networks derived from protein–protein, ...
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a bio-native AI company, today launched ReefIQ™, a HYFT-powered biological context layer for AI drug discovery and biologics development, that sits ...
CAMBRIDGE, Mass., April 22, 2026 — Insilico Medicine (“Insilico”, 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, recently published a comprehensive ...
CAMBRIDGE, Mass., April 22, 2026 /PRNewswire/ -- Target identification is the first and perhaps most critical step in drug discovery and development. Although the human genome contains roughly 20,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results